Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
BBP
67
HOLDINGS
19%
ALSO IN IDNA
IDNA
52
HOLDINGS
30%
ALSO IN BBP
SECTOR DRIFT (BBP minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 1.7% | 3.8% | 1.7% |
|
NUVATION BIO INC CLASS A | 1.7% | 2.1% | 1.7% |
|
REGENERON PHARMACEUTICALS | 1.6% | 4.2% | 1.6% |
|
INCYTE CORP | 1.6% | 4.0% | 1.6% |
|
VERTEX PHARMACEUTICALS INC | 1.6% | 3.9% | 1.6% |
BBP Overweight Relative to IDNA
|
DYNAVAX TECHNOLOGIES CORP | 2.2% |
|
AMICUS THERAPEUTICS INC | 2.1% |
|
AXSOME THERAPEUTICS, INC. | 1.9% |
|
MIRUM PHARMACEUTICALS, INC. | 1.9% |
|
PHATHOM PHARMACEUTICALS, INC. | 1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 1.7% |
|
BIOMARIN PHARMACEUTICAL INC | 1.7% |
|
TRAVERE THERAPEUTICS, INC. | 1.7% |
|
HALOZYME THERAPEUTICS INC | 1.7% |
|
SYNDAX PHARMACEUTICALS INC | 1.6% |
BBP Underweight Relative to IDNA
|
REVOLUTION MEDICINES, INC. | -5.7% |
 |
BAYER AG | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.3% |
|
MERCK & CO. INC. | -4.2% |
 |
ROCHE HOLDING LTD | -4.2% |
 |
GENMAB A/S | -4.1% |
 |
GSK PLC | -4.0% |
 |
IPSEN | -4.0% |
|
SANOFI-AVENTIS | -3.8% |
|
IDEAYA BIOSCIENCES, INC. | -3.5% |